Search

everythinglearnresearchcommunity

for

Search:↓

Keratin-based hydrogels with calcium are effective for delivering anti-fibrotic drugs.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

Computational methods help design drugs targeting prostate cancer proteins.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

Early diagnosis and treatment of TPP can prevent complications.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Serotonin helps wounds heal faster.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Testosterone changes how certain channels work in male rat reproductive tracts, affecting fertility-related fluid balance.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Compound 4 is a promising treatment for hair loss with low toxicity.

Enhanced stem cells from the placenta can reduce fat cell formation in eye disease.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Introducing the rat OTC gene partially corrected OTC deficiency in mice.

CRPS type I is a complex pain condition with no proven cure, requiring personalized treatment.

Human keratinocytes do not naturally respond to androgens.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

Reducing SFRP1 can promote hair growth and may help treat hair loss.